Skip to main content

Table 4 Univariate odds of treatment choice, ULT adherence and likelihood diet change for gout by gender, race and age

From: A cross-sectional internet-based patient survey of the management strategies for gout

Patient characteristics

Patient preference for choice of ULT as the treatment for gouta

Urate-lowering medication adherence >80 %b

Likelihood of diet changec

Gender

P = 0.04

P = 0.21

P = 0.15

   Male

0.64 (0.42, 0.98)*

0.62 (0.29, 1.31)

0.74 (0.50, 1.12)

   Female

Ref

Ref

Ref

Age groups

P = 0.32

P = 0.78

P = 0.02

   21–40

0.83 (0.24, 2.87)

0.89 (0.84, 9.44)

2.89 (0.58, 14.25)

   41–60

1.01 (0.32, 3.20)

1.32 (0.15, 11.52)

2.84 (0.61, 13.10)

   61–80

0.69 (0.22, 2.21)

1.58 (0.18, 13.96)

4.86 (1.05, 22.57)*

   >80

Ref

Ref

 

Race

P = 0.49

P = 0.66

P = 0.32

   African American

0.86 (0.43, 1.72)

0.49 (0.11, 2.23)

1.50 (0.77, 2.94)

   Hispanic or Latino

0.92 (0.31, 2.71)

0.94(0.11, 8.31)

0.93 (0.31, 2.82)

   Asian

0.55 (0.29, 1.03)

2.20(0.83, 5.80)

0.61(0.30, 1.21)

   American Indian or Alaskan native

-----

-----

3.34 (0.30, 37.15)

   Hawaiian or Pacific Islander

4.14 (0.50, 34.7)

1.17 (0.13, 10.85)

2.09 (0.55, 7.90)

   Other

0.86 (0.33, 2.24)

1.88(0.35, 10.10)

1.67 (0.65, 4.31)

   White/Caucasian

Ref

Ref

Ref

  1. *Odds ratio with p-value <0.05; bold represents either the variable or the variable category with p-value <0.05
  2. aReference category is preference for non-medications (cherry extract or gout-specific diet modification) as the treatment strategy for gout
  3. bReference category is urate-lowering medication adherence of >80 % in the last month compared to < =80 %
  4. cLikelihood of die change with score of 8 or more (score range 0–10; reference category <8)